Arduini Peter J 4

What Happened
Peter J. Arduini, a director of Bristol Myers Squibb (BMY), received an award of 607.428 deferred share units on 2026-06-30. The units are reported at a grant price of $57.62 each, for a total reported value of $35,000. The filing classifies this as an award/acquisition (derivative instrument), not an open-market purchase.

Key Details

• Transaction date: 2026-06-30; Form 4 filed: 2026-07-02 (generally within the two-business-day reporting window).
• Award: 607.428 Deferred Share Units; grant price used: $57.62; total value: $35,000.
• Shares owned after transaction: not specified in this Form 4.
• Footnotes: F1 — Deferred Share Units convert into common shares upon settlement (become settleable when the director leaves or at a previously specified settlement date). F2 — Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.
• Transaction code: A (award/acquisition); reported as a derivative grant.

Context
Deferred share unit awards are a form of director compensation and typically convert into actual shares at a later settlement date (often when the director departs or at a set future date). Such awards are routine compensation and do not necessarily indicate the director is buying or selling stock for investment purposes. The dollar amount here is modest (~$35k).